Abstract:The hepatocyte growth factor (HGF)/c-Met signaling aberrations are implicated in the pathogenesis and progress of hepatocellular carcinoma (HCC). However, the epigenetic regulators and their roles in modulating HGF-induced epithelial-mesenchymal transition (EMT), invasion and metastasis of HCC cells are less explored. SUMO/sentrin specific protease 1 (SENP1) is the cysteine protease that regulates SUMO pathways by deconjugating sumoylated proteins. Using real-time PCR we identified increased expression of SENP1 and c-Met in HCC tumors compared to adjacent noncancerous tissues (p<0.05, n=20). We further demonstrated that SENP1 overexpression is associated with HGF/c-Met signals in HCC. Treatment of HCC cells with HGF results in upregulation of SENP1 in a stat5 dependent manner. To explore the role of SENP1 in regulation of characteristics of HCC cells, we knocked down SENP1 in HCC cells lines using lentiviral vectors pLKO. 1-GFP-Senp1-shRNA. HCC-LM3 cells transduced with this vector demonstrated 77% decreased expression of SENP1 compared to cells transduced with a control vector. Lentivirus-mediated SENP1 knockdown triggers apoptosis (from control with 7.68% to Senp1 shRNA with 20.4%), cell cycle arrest and inhibits proliferation (80.6% inhibition, p<0.01) of HCC cells. SENP1 silence reduces HGF-induced migration of HCC cells (66.7% inhibition, p<0.01). Importantly, SENP1 inhibition increases E-cadherin and ZO-1 expression, and decrease fibronectin and N-cadherin expression in HCC cells. A series of transcription factors are involved in regulation of EMT processes. Zeb1 is a zinc finger transcription factor which induces an EMT and confers a metastatic phenotype on carcinomas. We predicted the sumoylation sites of Zeb1 by using a site-specific predictor of SUMOsp 2.0. This prediction was further validated by using Zeb-1 immunoprecipitation and Sumo2 antibody blot. HGF treatment also induced the expression of zeb1. SENP1 knockdown increased Zeb1 desumoylation, leading to reduce its protein level in HCC cells. Our results indicate that SENP1 is frequently over-expressed and associated with HGF/C-met in HCC. SENP1 plays a key role in HGF-induced proliferation, migration and epithelial-mesenchymal transition, suggesting it may be a potential new therapeutic target for HCC.

Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development.

PTPN11/Shp2 Overexpression Enhances Liver Cancer Progression and Predicts Poor Prognosis of Patients.

Shp2 Promotes Liver Cancer Stem Cell Expansion by Augmenting Β‐catenin Signaling and Predicts Chemotherapeutic Response of Patients

Shp2 Deficiency in Kupffer Cells and Hepatocytes Aggravates Hepatocarcinogenesis by Recruiting Non-Kupffer Macrophages

SHP2 Positively Regulates TGFβ1-induced Epithelial-Mesenchymal Transition Modulated by Its Novel Interacting Protein Hook1

SENP2 Regulates Hepatocellular Carcinoma Cell Growth by Modulating the Stability of Β-Catenin

Data from Akt SUMOylation Regulates Cell Proliferation and Tumorigenesis

Increased Small Ubiquitin-like Modifier-Activating Enzyme SAE1 Promotes Hepatocellular Carcinoma by Enhancing mTOR SUMOylation

Shp-2 tyrosine phosphatase is required for hepatocyte growth factor-induced activation of sphingosine kinase and migration in embryonic fibroblasts.

Polycomb Protein Ezh2 Activates Wnt/Beta-Catenin Signaling To Promote Hepatocellular Carcinoma Development

SENP1 is a Crucial Promotor for Hepatocellular Carcinoma Through Desumoylation of UBE2T

SKP2-mediated FBXO2 proteasomal degradation drives hepatocellular carcinoma progression via stabilizing Hsp47

Shp2 Regulates Migratory Behavior and Response to EGFR-TKIs Through ERK1/2 Pathway Activation in Non-Small Cell Lung Cancer Cells

Demethylation-induced overexpression of Shc 3 drives c-Raf-independent activation of MEK / ERK in HCC Short Title : Shc 3 / MVP / MEK / ERK promotes HCC progress

SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma

Shp2 Regulates Src Family Kinase Activity and Ras/Erk Activation by Controlling Csk Recruitment

589. SENP1 Knockdown Inhibits Hepatocyte Growth Factor-Induced Migration and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma

Src SUMOylation Inhibits Tumor Growth Via Decreasing FAK Y925 Phosphorylation.

Dysregulation and oncogenic activities of ubiquitin specific peptidase 2a in the pathogenesis of hepatocellular carcinoma

Phosphorylation of RasGRP1 by Shc3 prevents RasGRP1 degradation and contributes to Ras/c-Jun activation in hepatocellular carcinoma